Placement Completed
Nyrada placement
A$14m raised
Announced 21 Sep 2026 · ASX: NYR · A$0.62 cash per share
Advisers
Nyrada
Issuer
Not disclosed
Lead managers
- Lead manager
- Bookrunner
- Issuer
- Nyrada
- Completed
- 25 Sep 2026
- Sector
- Biotech and pharmaceuticals
Similar deals
- Paradigm Biopharmaceuticals placement Apr 2026 · A$14m · Biotech and pharmaceuticals
- Arovella Therapeutics placement Feb 2025 · A$15m · Biotech and pharmaceuticals
- Radiopharm Theranostics placement Jul 2026 · A$12.5m · Biotech and pharmaceuticals
- Recce Pharmaceuticals entitlement offer Jun 2025 · A$15.8m · Biotech and pharmaceuticals
- Actinogen Medical placement Feb 2026 · A$17m · Biotech and pharmaceuticals
Sources
- 21 Sep 2026 Nyrada Successfully Raises AU$12.0 Million Via Placement ASX
- 21 Sep 2026 Cap Raise Deck-Building the Future of TRPC-based Therapies ASX
- 25 Sep 2026 Application for quotation of securities - NYR ASX